ULS
Next earnings: Aug 4, 2026 · Before open
Signal
Bearish Setup1!1
Price
1
Move-1.59%Negative session
Volume
1
Volume0.5× avgNormal activity
Technical
1
RSIRSI 73Overbought
PRICE
Prev Close
100.60
Open
99.70
Day Range98.66 – 100.02
98.66
100.02
52W Range61.64 – 107.54
61.64
107.54
81% of range
VOLUME & SIZE
Avg Volume
798.4K
FUNDAMENTALS
P/E Ratio
57.6x
Premium valuation
EPS (TTM)
Div Yield
No dividend
Performance
1D
-1.59%
5D
-1.79%
1M
+9.49%
3M
+41.39%
6M
+14.27%
YTD
+25.54%
1Y
+39.34%
Best: 3M (+41.39%)Worst: 5D (-1.79%)
Quick Read
TrendInsufficient MA data
Momentum
BULLISH
revenue +7% YoY · 50% gross margin
Valuation
EXPENSIVE
P/E 58x vs ~20x sector
Health
STRONG
CR 1.2 · FCF $2.24/sh
Bullish
Key MetricsTTM
Market Cap$19.92B
Revenue TTM$3.11B
Net Income TTM$349.00M
Free Cash Flow$450.00M
Gross Margin49.6%
Net Margin11.2%
Operating Margin17.8%
Return on Equity28.4%
Return on Assets11.8%
Debt / Equity0.40
Current Ratio1.16
EPS TTM$1.74
Alpha SignalsFull Analysis →
What Moves This Stock

New regulatory mandates expanding certification requirements (e.g., battery safety standards for EVs, cybersecurity certifications for IoT devices)

Industrial capital expenditure cycles driving demand for equipment certification and factory audits

Cross-border trade volumes requiring multi-jurisdiction product certifications

Pricing actions on certification renewals and ability to pass through labor cost inflation

Macro Sensitivity
Economic Cycle

moderate - Revenue correlates with industrial production and manufacturing activity as companies launch new products requiring certification. However, the business benefits from defensive characteristics including regulatory mandates that persist through downturns and multi-year certification contracts providing revenue visibility. Consumer discretionary exposure (appliances, electronics) creates some cyclicality, offset by non-discretionary industrial and infrastructure testing. Estimated 60-70% correlation with industrial production cycles.

Interest Rates

Rising rates create modest headwinds through higher financing costs for the company's $1.1B debt load (0.62 D/E ratio) and potential valuation multiple compression given the 21.3x EV/EBITDA premium valuation. However, the asset-light model with strong FCF generation ($0.3B) limits refinancing risk. Customer demand shows low direct rate sensitivity as certification costs represent small fractions of total product development budgets, though rates indirectly impact demand through effects on manufacturing capex cycles.

Key Risks

Regulatory harmonization reducing need for multiple certifications across jurisdictions, potentially compressing volumes and pricing power

Technology disruption through AI-enabled virtual testing or blockchain-based certification systems reducing demand for physical laboratory services

Shift toward manufacturer self-certification in certain product categories as regulatory frameworks evolve

Investor Profile

growth - The stock attracts growth investors seeking exposure to secular trends in product safety, sustainability compliance, and electrification. The 25% net income growth, 32.6% ROE, and premium 4.7x P/S valuation indicate market expectations for continued above-GDP growth. Recent -19.8% three-month decline may attract value-oriented investors viewing the pullback as entry opportunity, though the 21.3x EV/EBITDA multiple remains elevated. Limited dividend yield (2.0% FCF yield) suggests capital appreciation focus over income.

Watch on Earnings
Industrial Production Index as leading indicator for manufacturing activity and certification demandGlobal manufacturing PMI trends indicating new product development cyclesElectric vehicle production volumes driving battery testing and certification revenueCommercial construction spending influencing building materials and fire safety testing demand
Health Radar
4 strong2 watch
70/100
Liquidity
1.16Watch
Leverage
0.40Strong
Coverage
14.9xStrong
ROE
28.4%Strong
ROIC
19.6%Strong
Cash
$295MWatch
ANALYST COVERAGE8 analysts
BUY
-1.0%downside to target
L $87.00
Med $98.00consensus
H $115.00
Buy
450%
Hold
450%
4 Buy (50%)4 Hold (50%)0 Sell (0%)
Full report →
Stock Health
Composite Score
3 of 5 signals bullish
8/10
Technicals
RSI RangeRSI 73 — Overbought, caution
~
Volume
Volume FlowAccumulation — institutional buying
Fundamentals
Last EarningsBeat estimates
Analyst ConsensusBuy
LiquidityCurrent Ratio 1.16
~
Upcoming Events
EEarnings ReportMay 17, 2026
Tomorrow
DEx-Dividend DateAug 14, 2026
In 90 days
PDividend PaymentAug 31, 2026
In 107 days
Technicals
Technical SetupBULLISH
Technicals →

Trend

UptrendGolden Cross · 50D leads 200D by 180.5%

+34.6% vs SMA 50 · +277.6% vs SMA 200

Momentum

RSI73.5
Overbought — pullback risk
MACD+8.10
Above zero — bullish momentum · expanding
Market Position
Price Levels
52W High
$107.5+8.6%
Current
$99.00
EMA 50
$76.87-22.4%
52W Low
$61.64-37.7%
EMA 200
$26.96-72.8%
52-Week RangeNear 52-week high
$61.6481th %ile$107.5
Squeeze SetupVolume-based
Moderate Squeeze Setup

Accumulation pattern present — more buying days than selling over the past 20 sessions. Volume conditions support gradual price improvement.

20-Day Money Flow
Acc days:3
Dist days:1
Edge:+2 acc
Volume Context
Avg Vol (50D)774K
Recent Vol (5D)
623K-20%

Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.

Earnings & Analysts

ANALYST ESTIMATES

Consensus of 8 analysts
Analyst revisions:EPS↑ Revised UpRevenue↑ Revised Up

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2023
$2.7B
$2.7B$2.8B
$1.30
±2%
High7
FY2024
$2.9B
$2.8B$3.0B
+5.1%$1.59+22.1%
±2%
High8
FY2025
$3.0B
$3.0B$3.1B
+6.6%$1.90+19.1%
±2%
High8
Range confidence:Tight (high)ModerateWide (low)
🔥Beat 8 consecutive quarters
Earnings HistoryULS
Last 8Q
+19.3%avg beat
Beat 8 of 8 quarters Estimates rising
+28%
Q3'24
+13%
Q4'24
+29%
Q1'25
+17%
Q2'25
+11%
Q3'25
+19%
Q4'25
+19%
Q1'26
+19%
Q2'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
Analyst Activity
All ratings →
No recent activity
CitigroupBuy → Neutral
May 14
DOWNGRADE
JefferiesOverweight
May 7
DOWNGRADE
Insider Activity
SEC Filings →
4 Buys/2 SellsNet Buying
NET SELLERS$0 bought · $2.6M sold · 30d window
Genovesi John ASee Remarks
$2K
Dec 8
BUY
Genovesi John ASee Remarks
$2K
Sep 8
BUY
Genovesi John ASee Remarks
$2K
Jun 9
BUY
Genovesi John ASee Remarks
$2K
Mar 10
BUY
Uggetti AlbertoEVP & CCO
$610K
May 11
SELL
Schjotz GitteSee Remarks
$832K
May 7
SELL
Financials
Dividends0.54% yield
+8.9% avg annual growth
Annual Yield0.54%
Semi-Annual Div.$0.1450
Est. Annual / Share$0.29
FrequencySemi-Annual
Q2'24
Q3'24
Q4'24
Q1'25
Q2'25
Q3'25
Q4'25
Q1'26

Dividend per payment — last 8 periods

INSTITUTIONAL OWNERSHIP

1
T. Rowe Price Investment Management, Inc.
7.3M
2
Capital International Investors
6.1M
3
BlackRock, Inc.
5.4M
4
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC
5.4M
5
Capital Research Global Investors
3.7M
6
Durable Capital Partners LP
3.3M
7
JANUS HENDERSON GROUP PLC
3.0M
8
BESSEMER GROUP INC
2.3M
News & Activity

ULS News

20 articles · 4h ago

About

No description available.

Patricia A. CrawfordSenior Vice President & Chief Information Officer
Yijing H. BrentanoVice President of Investor Relations
Alex G. DadakisExecutive VP and President of Testing, Inspection & Certification (TIC)
Peers(7 companies)
Screen sector →
SymbolPriceDay %Mkt CapP/ERev GrwMarginELO
ULS
$99.00-1.59%$19.9B57.0+637.6%1064.5%1500
$404.35-3.20%$2.1T30.5+3296.8%4510.0%1500
$132.58-6.05%$307.9B20.7-44.8%1012.0%1500
$88.38-2.58%$303.7B13.6+318.8%1510.7%1500
$148.08-1.13%$282.6B21.0+597.3%2564.4%1500
$181.58-1.83%$281.6B26.9+862.9%1745.9%1500
$183.40-0.23%$256.1B16.8+213.3%1482.4%1500
Sector avg-2.37%26.6+840.3%1984.3%1500